Antimicrobial susceptibility and molecular typing of MRSA in cystic fibrosis.
about
Inhaled Antibiotic Therapy in Chronic Respiratory Diseases.Multicenter Observational Study on Factors and Outcomes Associated with Various Methicillin-Resistant Staphylococcus aureus Types in Children with Cystic FibrosisSeasonality of acquisition of respiratory bacterial pathogens in young children with cystic fibrosisPharmacokinetics and pharmacodynamics of aerosolized antibacterial agents in chronically infected cystic fibrosis patients.Antibiotic management of methicillin-resistant Staphylococcus aureus--associated acute pulmonary exacerbations in cystic fibrosis.Outcomes and Treatment of Chronic Methicillin-Resistant Staphylococcus aureus Differs by Staphylococcal Cassette Chromosome mec (SCCmec) Type in Children With Cystic Fibrosis.FosfomycinOne Center's Guide to Outpatient Management of Pediatric Cystic Fibrosis Acute Pulmonary Exacerbation.2014 year in review: Cystic fibrosis.Microbiological efficacy of early MRSA treatment in cystic fibrosis in a randomised controlled trial.Changing Epidemiology of the Respiratory Bacteriology of Patients With Cystic Fibrosis.Infection prevention and control guideline for cystic fibrosis: 2013 update.Analysis of the spectrum and antibiotic resistance of uropathogens in outpatients at a tertiary hospital.Understanding the impact of antibiotic therapies on the respiratory tract resistome: a novel pooled-template metagenomic sequencing strategy
P2860
Q33755342-ADEC50B1-4E9F-4DD9-88B1-30E6EC6C695AQ33783497-1C8A7139-B10F-4EB1-9B36-6659C1E16758Q33785116-C2B9E226-4125-4120-8639-F0624B723D11Q34297656-E64E8A48-9579-43A4-9825-F50771F72FE4Q35542062-3628956E-2B4C-4E24-94E2-DD7B92AB9BC6Q36009637-31D10DAC-BD57-4890-946D-522C4AA5D2C1Q36675246-22D73B75-DDAE-4FAF-B3A2-66F73F2D9A4CQ37094805-97C8E8BD-55DC-4F8B-A10A-DA2512A24AE3Q38582563-53E5DBEC-2130-4CB2-AF3F-6DEB7E3B0CEBQ40449041-2F576AA9-693C-477B-B431-D90618A4E285Q40704655-BCBCA334-FC47-425D-93B8-2429294BD6F0Q42206103-901DB5F5-4A1B-47E6-8318-128754CB8DD9Q50165072-FB0DED6A-B9FB-44B9-8FFD-B5B1CEE2AD28Q56523707-45E3934D-0817-4A77-A4DC-0DB62364DEEB
P2860
Antimicrobial susceptibility and molecular typing of MRSA in cystic fibrosis.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Antimicrobial susceptibility and molecular typing of MRSA in cystic fibrosis.
@en
Antimicrobial susceptibility and molecular typing of MRSA in cystic fibrosis.
@nl
type
label
Antimicrobial susceptibility and molecular typing of MRSA in cystic fibrosis.
@en
Antimicrobial susceptibility and molecular typing of MRSA in cystic fibrosis.
@nl
prefLabel
Antimicrobial susceptibility and molecular typing of MRSA in cystic fibrosis.
@en
Antimicrobial susceptibility and molecular typing of MRSA in cystic fibrosis.
@nl
P2093
P2860
P356
P1476
Antimicrobial susceptibility and molecular typing of MRSA in cystic fibrosis.
@en
P2093
E A Champion
E B Popowitch
M B Miller
M S Muhlebach
STAR-CF Study Team
P2860
P304
P356
10.1002/PPUL.22815
P577
2013-06-14T00:00:00Z